Effect of Bosentan on Pulmonary Hypertension Secondary to Systolic Heart Failure

Publisher： Karger

E-ISSN： 1423-0313|92|5-6|281-285

ISSN： 0031-7012

Source： Pharmacology, Vol.92, Iss.5-6, 2013-11, pp. : 281-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Inotropic Agents in Treatment of Systolic Heart Failure

By Tariq Sohaib   Aronow Wilbert S.  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 29060-29068

MDPI

Access to resources Recommend Favorite

Bosentan Pharmacokinetics in Pediatric Patients with Pulmonary Arterial Hypertension: Comparison of Dried Blood Spot and Plasma Analysis

By  

Pharmacology, Vol. 98, Iss. 3-4, 2016-05 ,pp. : 111-114

Karger

Access to resources Recommend Favorite

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD

By Kato Mahoto   Komamura Kazuo   Kitakaze Masafumi   Hirayama Atsushi  

Diseases, Vol. 6, Iss. 1, 2017-12 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite

Acute and Long-Term Efficacy and Safety of Sildenafil for the Treatment of Chronic Thromboembolic Pulmonary Hypertension in a Heart Transplant Recipient

By  

Pharmacology, Vol. 87, Iss. 1-2, 2010-12 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

DNA Damage and Pulmonary Hypertension

By Ranchoux Benoît   Meloche Jolyane   Paulin Roxane   Boucherat Olivier   Provencher Steeve   Bonnet Sébastien  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 990-990

MDPI

Access to resources Recommend Favorite